Clinical trial
Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With…
NCT00104715 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00104715 |
|---|---|
| Title | Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer |
| Official title | Randomized Phase III Trial Comparing an Association of Hormonal Treatment and Docetaxel Versus the Hormonal Treatment Alone in Metastatic Prostate Cancers |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Procedure |
| Interventions | antiandrogen therapy, docetaxel, goserelin acetate, orchiectomy |
| Enrollment | 385 |
| Start date | Oct 18, 2004 |
| Primary completion | Dec 4, 2011 |
| Completion | Dec 15, 2015 |
| First posted | Mar 4, 2005 |
| Last update posted | Feb 21, 2021 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: